Microbiota potential for the treatment of sexual dysfunction

Medical Hypotheses

Volumn 115, Issue , 2018, Pages 46-49

  Tirandaz, Hassan ^a   Ebrahim Habibi, Mohammad Bagher ^a   Moradveisi, Borhan ^b   Raoofi, Saeid ^c   Salehi Najafabadi, Amir ^d   Mohammadi, Ebrahim ^b  

^a RESEARCH INSTITUTE OF PETROLEUM INDUSTRY RIPI   (Iran)

^b KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c FARHANGIAN UNIVERSITY   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Diabetes; Hypertension; Microbiota; Sex hormones; Sexual dysfunction

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; SEX HORMONE;

ANXIETY; ARTICLE; BACTERIAL THERAPY; BIOLOGICAL THERAPY; COMORBIDITY; CORRELATIONAL STUDY; DIABETES MELLITUS; DIET; ENDOCRINE DISEASE; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; HYPERTENSION; HYPOTHESIS; INTESTINE FLORA; MICROFLORA; MICROMANIPULATION; MOOD; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; STRESS; THERAPY EFFECT; ANIMAL; BIOLOGICAL MODEL; FEMALE; MALE; MICROBIOLOGY; PHYSIOLOGY; SEXUALITY;

ANIMALS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; MICROBIOTA; MODELS, BIOLOGICAL; PREBIOTICS; PROBIOTICS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUALITY;

EID: 85055602501     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2018.03.021     Document Type: Article

References (50)

1. Hooper, L.V., Midtvedt, T., Gordon, J.I., How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22 (2002), 283–307.
2. Rooks, M.G., Garrett, W.S., Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16 (2016), 341–352.
3. Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13 (2012), 701–712.
4. Nicholson, J.K., Holmes, E., Kinross, J., et al. Host-gut microbiota metabolic interactions. Science 336 (2012), 1262–1267.
5. Farrell, J.J., Zhang, L., Zhou, H., et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 61 (2012), 582–588.
6. Yoshimoto, S., Loo, T.M., Atarashi, K., et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499 (2013), 97–101.
7. Remot, A., Descamps, D., Noordine, M.L., et al. Bacteria isolated from lung modulate asthma susceptibility in mice. ISME J 11 (2017), 1061–1074.
8. Karlsson, F.H., Fåk, F., Nookaew, I., et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun, 3, 2012, 1245.
9. Choi, S.C., Mohmadzadeh, M., Morel, L., Gut dysbiosis contributes to autoimmune pathogenesis in lupus-prone mice. J Immunol, 198, 2017, 2.
10. Scher, J.U., Sczesnak, A., Longman, R.S., et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife, 2, 2013, e01202.
11. Scheperjans, F., Aho, V., Pereira, P.A., et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 30 (2015), 350–358.
12. Jubair, W.K., Hendrickson, J.D., Severs, E.L., et al. Modulation of inflammatory arthritis by gut microbiota through mucosal inflammation and autoantibody generation. Arthritis Rheumatol, 2018.
13. Ostojic, S.M., Inadequate production of H2 by gut microbiota and Parkinson disease. Trends Endocrinol Metab, 2018 pii: S1043-2760(18)30027-4.
14. Fei, N., Zhao, L., An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J 7 (2013), 880–884.
15. Laumann, E.O., Paik, A., Rosen, R.C., Sexual dysfunction in the United States: prevalence and predictors. JAMA 281 (1999), 537–544.
16. Hatzimouratidis, K., Amar, E., Eardley, I., et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 57 (2010), 804–814.
17. Joscelyn, J., Kasper, L.H., Digesting the emerging role for the gut microbiome in central nervous system demyelination. Mult Scler 20 (2014), 1553–1559.
18. Tremellen, K., Pearce, K., Dysbiosis of Gut Microbiota (DOGMA) – a novel theory for the development of Polycystic Ovarian Syndrome. Med Hypotheses 79 (2012), 104–112.
19. Rees, J.C., Obsessive-compulsive disorder and gut microbiota dysregulation. Med Hypotheses 82 (2014), 163–166.
20. Skosnik, P.D., Cortes-Briones, J.A., Targeting the ecology within: the role of the gut-brain axis and human microbiota in drug addiction. Med Hypotheses 93 (2016), 77–80.
21. Ajo, R., Segura, A., Mira, L., et al. The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD). Aging Male 18 (2016), 1–8.
22. Markle, J.G., Frank, D.N., Mortin-Toth, S., et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339 (2013), 1084–1088.
23. Markle, J.G., Frank, D.N., Adeli, K., von Bergen, M., Danska, J.S., Microbiome manipulation modifies sex-specific risk for autoimmunity. Gut Microbes 5 (2014), 485–493.
24. Yurkovetskiy, L., Burrows, M., Khan, A.A., et al. Gender bias in autoimmunity is influenced by microbiota. Immunity 39 (2013), 400–412.
25. Tekin, A., Meriç C., Sağbilge, E., et al. The relationship between childhood sexual/physical abuse and sexual dysfunction in patients with social anxiety disorder. Nord J Psychiatry 70 (2016), 88–92.
26. Neufeld, K.M., Kang, N., Bienenstock, J., Foster, J.A., Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 23 (2011), 255–264.
27. Dinan, T.G., Cryan, J.F., Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology 37 (2012), 1369–1378.
28. Messaoudi, M., Lalonde, R., Violle, N., et al. Assessment of psychotropic-like properties of a probiotic formulation [Lactobacillus helveticus R0052 and Biidobacterium longum R0175] in rats and human subjects. Brit J Nutr 105 (2011), 755–764.
29. Esposito, K., Giugliano, F., Ciotola, M., De Sio, M., D'Armiento, M., Giugliano, D., Obesity and sexual dysfunction, male and female. Int J Impot Res 20 (2008), 358–365.
30. Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Human gut microbes associated with obesity. Nature 444 (2006), 1022–1023.
31. Ridaura, V.K., Faith, J.J., Rey, F.E., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
32. Kizilay, F., Gali, H.E., Serefoglu, E.C., Diabetes and Sexuality, Sex. Med Rev 5 (2017), 45–51.
33. Wen, L., Ley, R.E., Volchkov, P.Y., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455 (2008), 1109–1113.
34. Cani, P.D., Bibiloni, R., Knauf, C., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481.
35. Qin, J., Li, Y., Cai, Z., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60.
36. Bäckhed, F., Ding, H., Wang, T., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101 (2004), 15718–15723.
37. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
38. Cani, P.D., Amar, J., Iglesias, M.A., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
39. De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156 (2014), 84–96.
40. Doumas, M., Tsiodras, S., Tsakiris, A., et al. Female sexual dysfunction in essential hypertension: a common problem being uncovered. J Hypertens 24 (2006), 2387–2392.
41. Yang, T., Santisteban, M.M., Rodriguez, V., et al. Gut dysbiosis is linked to hypertension. Hypertension 65 (2015), 1331–1340.
42. Jose, P.A., Raj, D., Gut microbiota in hypertension. Curr Opin Nephrol Hypertens 24 (2015), 403–409.
43. Lagier, J.C., Khelaifia, S., Alou, M.T., et al. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat Microbiol, 1, 2016, 16203.
44. Bakker, G.J., Nieuwdorp, M., Fecal microbiota transplantation: therapeutic potential for a multitude of diseases beyond Clostridium difficile. Microbiol Spectr, 5, 2017.
45. Everard, A., Matamoros, S., Geurts, L., Delzenne, N.M., Cani, P.D., Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice. MBio 5 (2014), e01011–e01014.
46. Poutahidis, T., Springer, A., Levkovich, T., et al. Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice. PLoS One, 9, 2014, e84877.
47. Bindels, L.B., Delzenne, N.M., Cani, P.D., Walter, J., Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 2 (2015), 303–310.
48. Malviya, N., Malviya, S., Jain, S., Vyas, S., A review of the potential of medicinal plants in the management and treatment of male sexual dysfunction. Andrologia 8 (2016), 880–893.
49. Hong, B., Ji, Y.H., Hong, J.H., Nam, K.Y., Ahn, T.Y., A double-blind crossover study evaluating the efficacy of Korean red ginseng in patients with erectile dysfunction: a preliminary report. J Urol 168 (2002), 2070–2073.
50. Song, M.Y., Kim, B.S., Kim, H., Influence of Panax ginseng on obesity and gut microbiota in obese middle-aged Korean women. J Ginseng Res 38 (2014), 106–115.